Your browser doesn't support javascript.
loading
Acute Portal Vein Thrombosis Secondary to COVID-19 Vaccination.
Repp, Matthew L; Cohen, Seth; Kibbey, Caitlin.
Affiliation
  • Repp ML; Emergency Medicine, University of Arizona, Tucson, USA.
  • Cohen S; Emergency Medicine, University of Texas-Southwestern, Dallas, USA.
  • Kibbey C; Emergency Medicine, University of Texas-Southwestern, Dallas, USA.
Cureus ; 14(7): e26825, 2022 Jul.
Article in En | MEDLINE | ID: mdl-35971366
ABSTRACT
Portal vein thrombosis (PVT) is a partial or complete occlusion of the hepatic portal vein most frequently seen in patients with cirrhotic liver disease. Various non-cirrhotic conditions including inherited prothrombic blood disorders, neoplasms, and inflammatory diseases create hypercoagulable states that predispose individuals to blood clotting. Rarely does an exhaustive workup leave the etiology of a PVT unknown or unclear, and even more uncommon is a potential new etiology suspected. Our patient is a 34-year-old female, with no significant risk factors for pathologic clotting, who was diagnosed with an acute PVT several days after receiving the Moderna coronavirus disease 2019 (COVID-19) vaccine.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Cureus Year: 2022 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Cureus Year: 2022 Document type: Article Affiliation country: United States